Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the audited standalone and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sampre Nutritions Limited has notified BSE that a Board meeting is scheduled for May 29, 2026. The meeting will consider and approve the audited standalone and consolidated financial results for Q4 and the full year ended March 31, 2026. This is a routine regulatory filing under SEBI Listing Regulations. The company is a nutraceutical/food products manufacturer based in Medchal, Telangana, with its stock listed on BSE (Scrip Code: 530617). The meeting notice was signed by Managing Director Brahma Gurbani.
This is a standard pre-result announcement filing. No immediate impact on shareholders until actual financial results are disclosed. Investors should monitor for the results release after the board meeting concludes on May 29, 2026.